![discount label](https://static.cymitquimica.com/public/img/discount.png)
Product Information
Ticagrelor-d7 is a chromatographic, spectrometric, and bioequivalence analyte that is used for the treatment of acute coronary syndrome. It inhibits platelet aggregation by blocking the P2Y12 receptor on the platelet membrane. The drug is administered orally, and its pharmacokinetics are linear with a low propensity for accumulation. Ticagrelor-d7 has been shown to be equivalent to ticagrelor in terms of pharmacokinetics and antiplatelet activity in humans.
Chemical properties
Technical inquiry about: 3D-QAC91155 Ticagrelor-d7
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.